Teri S Krebs's research while affiliated with Norwegian University of Science and Technology and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (13)
A recent large population study of 130,000 adults in the United States failed to find evidence for a link between psychedelic use (lysergic acid diethylamide, psilocybin or mescaline) and mental health problems. Using a new data set consisting of 135,095 randomly selected United States adults, including 19,299 psychedelic users, we examine the asso...
The classical serotonergic psychedelics LSD, psilocybin, mescaline are not known to cause brain damage and are regarded as non-addictive. Clinical studies do not suggest that psychedelics cause long-term mental health problems. Psychedelics have been used in the Americas for thousands of years. Over 30 million people currently living in the US have...
We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of peop...
Assessments of lysergic acid diethylamide (LSD) in the treatment of alcoholism have not been based on quantitative meta-analysis. Hence, we performed a meta-analysis of randomized controlled trials in order to evaluate the clinical efficacy of LSD in the treatment of alcoholism. Two reviewers independently extracted the data, pooling the effects us...
Neuropsychopharmacology, the official publication of the American College of Neuropsychopharmacology, publishing the highest quality original research and advancing our understanding of the brain and behavior.
The aims of this study were to examine whether a change in overall defensive functioning during treatment a) would predict change in symptom distress during the course of treatment and follow-up and b) would be greater in short-term dynamic therapy than in cognitive therapy. Patients (N = 50) who met criteria for cluster C personality disorders wer...
Exposure therapy is known to be an effective treatment for anxiety disorders. Nevertheless, exposure is not used as much as it should be, and instead patients are often given supportive medications such as serotonin reuptake inhibitors (SSRIs) and benzodiazepines, which may even interfere with the extinction learning that is the aim of treatment. G...
Unlike nearly all previous research on the issue of potential long-term effects of Ecstasy use, the Netherlands XTC Toxicity team used a prospective study design, assessing people before and after they decided to take Ecstasy. It is precisely because Schilt and colleagues1 are engaged in conducting one of the most ambitious and carefully thought ou...
Citations
... It is important to understand that all medications have the potential for healing or abuse, depending on how they are used, and psychedelics are no exception. That being said, the data indicate that compared to other substances, psychedelics are generally safe, with low addiction potential, and even recreational use is correlated to few negative outcomes (Johansen & Krebs, 2015). ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/517536519122948-1500401729598_Q64/Pal-Orjan-Johansen.jpg)
... Grob et al., 2011) and inducing meaningful experiences in healthy volunteers (Elsey, 2017;Griffiths et al., 2006). Ability to have reduced anxiety when facing death and meaningful experiences when alive is argued to be not only "human enhancement", but close to a human right (Krebs, 2015), especially from the standpoint of cognitive liberty (Walsh, 2016). ...
... All covariates were coded separately. The inclusion of these covariates broadly mirrors those used in prior investigations of lifetime classic psychedelic use in the United States population (Johansen & Krebs, 2015;Krebs & Johansen, 2013;Simonsson, Sexton, & Hendricks, 2021) with the exception of employment type, annual respondent income, overall health, and BMI. These additional covariates were included as they were expected or have previously been shown to predict workplace absenteeism (DeVaro, 2015;Frone, 2008;Merrill et al., 2013;Schmier, Jones, & Schmier, 2006;Yun, Sim, Park, Park, & Noh, 2016). ...
... Future studies could measure and control for participants' preexisting attitudes toward psychedelics. However, lifetime psychedelic use in our sample was notably lower than estimates in the general population (Krebs and Johansen 2013) suggesting that participants were not unduly influenced by personal experiences with psychedelics. In our sample, the image induction prime did not have an impact on perceptions of CBT. ...
... However, it seems likely that some of the higher prLSD among older Americans is attributable to the legacy of in ammatory social discourse on LSD in the 1960s, which centered around highly publicized claims about terrifying purported LSD side effects such as chromosomal damage, cancer, birth defects, and long term psychosis in users, which have not been supported by subsequent research. [35][36][37][38][39] The association we observed between lower prLSD and identifying as a sexual minority is in line with previous ndings among people who have never used LSD. 40 Our identi ed association between higher education level and lower prLSD contrasts with previous studies showing positive associations between education level and perceived risk of marijuana and heroin. ...
... Medication paradigms similar to therapeutic regimes evidence positive effects, whereas regimes resembling human abuse pattern reveal neurotoxic effects (Advokat 2007). In conclusion, the vast majority of research concerning "Ecstasy" appears to be inapplicable in order to establish the risks and potentials of the application of MDMA in clinical settings (Cole and Sumnall 2003;Krebs and Johansen 2012). ...
... Preliminary clinical studies show that psychedelic therapy may have a therapeutic role in overcoming alcohol use disorder (Bogenschutz et al., 2022;Krebs & Johansen, 2012) and nicotine addiction Johnson et al., 2014;Noorani et al., 2018). Several trials are underway to explore psychedelic therapy for other addiction disorders (e.g. ...
... Attention was also drawn to the fact that some of the 'novice' users had used ten times more than the group average and it could, therefore, not be qualified as low/light use. Furthermore, there were no available data on the dose itself, and high doses cannot be excluded [30]. In another prospective study, no effects of Ecstasy use on verbal memory were shown. ...
... In a sample of young adults with adjustment disorders (mainly with mixed anxiety and depressive symptoms), Kramer (2010) showed prior improvement in defensive functioning mediated change in distress. The shortterm mutability of mature and immature defenses was also found in cluster C personality disorders treated with cognitive behavioral therapy (Johansen et al., 2011). ...
... Blood decreases were also observed in regions central to negative emotional processing, including temporal lobe, left amygdala, cingulate cortex, right anterior insula and thalamus (29,30). This may suggest a reduction in activity of these emotional centers involved in overactive threat responses, such as those suffering from PTSD and anxiety (31). ...
